- Steven Brandes, Washington University
- Cosimo De Nunzio, Ospedale Sant'Andrea
- John Gearhart, Johns Hopkins Children's Center
- Debra E Irwin, University of North Carolina at Chapel Hill
- Jose Karam, MD Anderson Cancer Center
- Ercan Kocakoc, Bezmialem Vakif University
- Salvatore Micali, University of Modena and Reggio Emilia
- Charles J Rosser, University of Florida
- Mostafa Taymour, University of Cairo
- Hayley Henderson, BioMed Central
Reduced RNA-binding motif protein 3 (RBM3) expression is associated with more aggressive tumours and reduced survival rates in patients with urothelial bladder cancer, and could be used as a prognostic biomarker for treatment stratification in patients with this disease.
Type 2 diabetes is associated with prevalent lower urinary tract symptoms (LUTS) in men, particularly those who are on active pharmaceutical treatment, but there is no association between type 2 diabetes and the onset of new LUTS.
Marco Rosa et al. review new treatments and technologies in the management of renal and ureteral calculi, and discuss the promising advances expected from the use of robotic-assisted procedures.
MDM2 SNP309 promoter polymorphism and p53 mutations are not associated with worse prognosis in primary T1 urinary bladder carcinoma patients, but abnormal p16 expression with mutated p53 gene shows increased rate of bladder cancer and shorter time to progression.
Charles Rosser et al. review the efficacy of radiation therapy in prostate cancer and discuss the intrinsic microenvironment of tumours and how radiosensitizing agents may be used to improve the efficacy of radiation therapy.
- View more articles
BMC Urology 2013, 13:30
BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Urology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at firstname.lastname@example.org, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
BMC series blog
Section Editor Profile
Cosimo De Nunzio, MD, PhD, is Consultant Urologist and contract Professor at the Department of Urology, Ospedale Sant'Andrea, University "La Sapienza", Roma, Italy. His research focus is prostatic disorders with a particular interest in voiding dysfunction, Benign prostatic Hyperplasia and prostate cancer diagnosis and management.
"I am pleased to be involved with BMC Urology first as a reviewer and now as Section Editor for Voiding Dysfunction. BMC Urology is an open access journal publishing original peer-reviewed articles, currently 10th on the SCImago Journal & Country Rank table and with and increasing number of manuscripts published in the last 4 years. When I joined BMC Urology, I have been particularly impressed by the excellent group of Section and Associate Editors involved in the Editorial Board and notwithstanding their young age, they are extremely expert in their field of interest. The journal's excellent editorial staff and the rapidity of the peer review process is another crucial quality of this journal. Moreover, I strongly support the open access platform used by BMC Urology which makes the specialized knowledge of urology more widely available to the scientific community at large, independently of the institutional affiliation or economic resources."